ATE237690T1 - Fk-506 cytosolisches bindeprotein - Google Patents

Fk-506 cytosolisches bindeprotein

Info

Publication number
ATE237690T1
ATE237690T1 AT95910231T AT95910231T ATE237690T1 AT E237690 T1 ATE237690 T1 AT E237690T1 AT 95910231 T AT95910231 T AT 95910231T AT 95910231 T AT95910231 T AT 95910231T AT E237690 T1 ATE237690 T1 AT E237690T1
Authority
AT
Austria
Prior art keywords
protein
proline
binds
binding protein
binding
Prior art date
Application number
AT95910231T
Other languages
English (en)
Inventor
Gregory J Wiederrecht
Tonya J Sewell
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE237690T1 publication Critical patent/ATE237690T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9493—Immunosupressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT95910231T 1994-02-15 1995-02-10 Fk-506 cytosolisches bindeprotein ATE237690T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/197,795 US5457182A (en) 1994-02-15 1994-02-15 FK-506 cytosolic binding protein, FKBP12.6
PCT/US1995/001721 WO1995021861A1 (en) 1994-02-15 1995-02-10 Fk-506 cytosolic binding protein

Publications (1)

Publication Number Publication Date
ATE237690T1 true ATE237690T1 (de) 2003-05-15

Family

ID=22730799

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95910231T ATE237690T1 (de) 1994-02-15 1995-02-10 Fk-506 cytosolisches bindeprotein

Country Status (9)

Country Link
US (1) US5457182A (de)
EP (1) EP0749443B1 (de)
JP (1) JP3747063B2 (de)
AT (1) ATE237690T1 (de)
CA (1) CA2181803A1 (de)
DE (1) DE69530378T2 (de)
DK (1) DK0749443T3 (de)
ES (1) ES2194903T3 (de)
WO (1) WO1995021861A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2042093C (en) * 1990-05-09 2002-12-24 Gyula Hadlaczky Cell line carrying an excess of mammalian centromeres
JPH07250686A (ja) * 1994-03-10 1995-10-03 Otsuka Pharmaceut Co Ltd Ｆｋ５０６結合蛋白遺伝子
MX9603838A (es) 1994-03-10 1997-03-29 Fujisawa Pharmaceutical Co Metodo para ensayar inmunosupresores.
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
JPH0924269A (ja) * 1995-07-10 1997-01-28 M Technic Kk リン脂質を使ったマイクロカプセルの製造方法
US6247995B1 (en) 1996-02-06 2001-06-19 Bruce Bryan Bioluminescent novelty items
US5876995A (en) 1996-02-06 1999-03-02 Bryan; Bruce Bioluminescent novelty items
US6077697A (en) * 1996-04-10 2000-06-20 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US20020160970A1 (en) * 1996-04-10 2002-10-31 Gyula Hadlaczky Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6025155A (en) * 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US20030033617A1 (en) * 1996-04-10 2003-02-13 Gyula Hadlaczky Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
WO1998024886A1 (en) * 1996-12-04 1998-06-11 Brigham And Women's Hospital, Inc. Mast cell protease that cleaves fibrinogen
US5955431A (en) * 1997-02-05 1999-09-21 Brigham And Women's Hospital, Inc. Mast cell protease peptide inhibitors
CA2331382A1 (en) * 1998-06-18 1999-12-23 Curagen Corporation Interaction of p27(kip1) with fkbp-12
ES2226409T3 (es) 1998-07-17 2005-03-16 Agouron Pharmaceuticals, Inc. Compuestos, composiciones y procedimientos para estimular el crecimiento y elongacion neuronales.
DE19907598A1 (de) * 1999-02-22 2000-08-24 Schulz Burkhard DNA Sequenz kodierend ein FKBP ähnliches Protein, Plasmide, Bakterien, Hefen und Pflanzen enthaltend dieses Protein sowie Mutanten in Arabidopsis für dieses Gen, die in der Ausprägung der Pflanzenarchitektur, der Reaktion gegenüber Brassinosteroiden und ihren Verbindungen und durch Ethylen vermittelten Gravitropismus der Wurzel defekt sind
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
WO2001012790A2 (en) * 1999-08-17 2001-02-22 Incyte Genomics, Inc. Isomerase proteins
ATE264863T1 (de) * 1999-08-24 2004-05-15 Ariad Gene Therapeutics Inc 28-epirapaloge
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
US7220552B1 (en) * 1999-11-19 2007-05-22 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and their use in the disruption of protein-protein interactions
CN1301770A (zh) * 1999-12-29 2001-07-04 复旦大学 一种新的多肽——人fkbp蛋白11和编码这种多肽的多核苷酸
US6489335B2 (en) * 2000-02-18 2002-12-03 Gholam A. Peyman Treatment of ocular disease
US7393652B2 (en) * 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7879840B2 (en) 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7312044B2 (en) 2003-03-07 2007-12-25 The Trustees Of Columbia University In The City Of New York Type 1 ryanodine receptor-based methods
US7718644B2 (en) 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
CN101845446B (zh) * 2000-09-28 2016-01-20 生物源食物及科学公司 脂肪酸去饱和酶家族成员fad4、fad5、fad5-2和fad6及它们的应用
CA2492153C (en) 2002-07-16 2012-05-08 Biotica Technology Limited Production of polyketide fkbp-ligand analogues
US6930127B2 (en) * 2002-08-15 2005-08-16 Eaton Veterinary Laboratories, Inc. Veterinary treatment of ophthalmic disease in animals using topical tacrolimus
US7544678B2 (en) 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
US7354574B2 (en) * 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
WO2004062669A1 (en) * 2003-01-16 2004-07-29 Sucampo Ag Use of a macrolide compound for treating dry eye
US7083802B2 (en) * 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US20050181018A1 (en) * 2003-09-19 2005-08-18 Peyman Gholam A. Ocular drug delivery
US7087237B2 (en) * 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) * 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
GB0417852D0 (en) 2004-08-11 2004-09-15 Biotica Tech Ltd Production of polyketides and other natural products
US20060189551A1 (en) * 2004-10-04 2006-08-24 Duke University Combination therapies for fungal pathogens
EP1904056B1 (de) 2005-07-18 2009-04-29 Minu, L.L.C. Verwendung von Makroliden zur Wiederherstellung der Kornealempfindungen
US20070014760A1 (en) * 2005-07-18 2007-01-18 Peyman Gholam A Enhanced recovery following ocular surgery
US7704990B2 (en) 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7642059B2 (en) * 2005-09-07 2010-01-05 Roche Diagnostics Operations, Inc. Single receptor assays for immunosuppressive drugs
US8921642B2 (en) * 2008-01-11 2014-12-30 Massachusetts Eye And Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
EP3008192B1 (de) 2013-06-11 2019-07-17 Takara Bio USA, Inc. Proteinangereicherte mikrovesikel und verfahren zur herstellung und verwendung davon

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3886265T2 (de) * 1987-06-05 1994-04-28 Fujisawa Pharmaceutical Co Anti-FR-900506-Stoffe-Antikörper und höchstempfindliches Enzym-Immunoassay-Verfahren.
US5109112A (en) * 1989-01-19 1992-04-28 Merck & Co., Inc. FK-506 cytosolic binding protein
WO1991004321A1 (en) * 1989-09-25 1991-04-04 President And Fellows Of Harvard College Receptor for fk-506
CA2063580C (en) * 1990-05-09 2002-11-19 Steven J. Soldin Receptor assay for fk-506
JP2982908B2 (ja) * 1990-07-11 1999-11-29 東燃株式会社 ヒトｆｋ５０６結合蛋白質をコードするｄｎａ
CA2052928A1 (en) * 1990-10-15 1992-04-16 John J. Siekierka Genes encoding the human fk-506 binding protein and a.s. cerevisiae homolog, fkb1 and their expression
AU2007192A (en) * 1991-05-08 1992-12-21 Vertex Pharmaceuticals Incorporated Rfkbp: a novel prolyl isomerase and rapamycin/fk506 binding protein
AU2803692A (en) * 1991-10-11 1993-05-03 Vertex Pharmaceuticals Incorporated Isolation of an mr 52,000 fk506 binding protein and molecular cloning of a corresponding human cdna
WO1993023548A2 (en) * 1992-05-20 1993-11-25 Vertex Pharmaceuticals Incorporated METHOD OF DETECTING TISSUE-SPECIFIC FK506 BINDING PROTEIN MESSENGER RNAs AND USES THEREOF
JPH07250686A (ja) * 1994-03-10 1995-10-03 Otsuka Pharmaceut Co Ltd Ｆｋ５０６結合蛋白遺伝子

Also Published As

Publication number Publication date
DE69530378D1 (de) 2003-05-22
EP0749443A4 (de) 1999-11-17
CA2181803A1 (en) 1995-08-17
DK0749443T3 (da) 2003-06-02
JP3747063B2 (ja) 2006-02-22
EP0749443A1 (de) 1996-12-27
DE69530378T2 (de) 2003-12-18
EP0749443B1 (de) 2003-04-16
WO1995021861A1 (en) 1995-08-17
JPH09509160A (ja) 1997-09-16
ES2194903T3 (es) 2003-12-01
US5457182A (en) 1995-10-10

Similar Documents

Publication Publication Date Title
ATE237690T1 (de) Fk-506 cytosolisches bindeprotein
Murrell A radical proposal for the pathogenesis of scleroderma
Yaron et al. Proline-dependent structural and biological properties of peptides and proteins
Burns et al. Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108-15 cells.
US5109112A (en) FK-506 cytosolic binding protein
US4563349A (en) Superoxide dismutase, its immobilized form, and their production and use
WO1995005455A1 (en) Pharmaceutical composition comprising phosphatase or a derivative thereof
IE75885B1 (en) Lipopeptide deacylase
Noyes et al. Structural and functional similarities between mitochondrial malate dehydrogenase and L-3-hydroxyacyl CoA dehydrogenase
Rascón et al. Purification and properties of the cGMP-inhibited cAMP phosphodiesterase from bovine aortic smooth muscle
Shapiro et al. The relationship of α-l-iduronidase and Hurler corrective factor
Sardanelli et al. Topology of the mitochondrial cAMP‐dependent protein kinase and its substrates
AU669540B2 (en) Monoclonal antibody against protein C
AU694161B2 (en) Method for selective methionine starvation of malignant cells in mammals
Lidström-Olsson et al. The role of sterol carrier protein2 and other hepatic lipid-binding proteins in bile-acid biosynthesis
CA2008149A1 (en) Fk-506 cytosolic binding protein
O'Malley et al. Genes for catecholamine biosynthesis: cloning by expression and identification of the cDNA for rat dopamine beta-hydroxylase.
US5196352A (en) New FK-506 cytosolic binding protein
NAKANO et al. Isolation and characterization of four forms of trehalase from rabbit kidney cortex
Kuo et al. Regulatory effects of S-100 protein and parvalbumin on protein kinases and phosphoprotein phosphatases from brain and skeletal muscle
US20090124553A1 (en) Suppression of inflammation associated with transplantation using an epsilon PKC inhibitor
Shichi et al. Purification and properties of anionic glutathione S-transferase from bovine ciliary body
Kanemitsu et al. Characterization of human creatine kinase BB and MB isoforms by means of isoelectric focusing
Becker et al. Purification of pyruvate kinase isoenzymes type M1 and M2 from dog (Canis familiaris) and comparison of their properties with those from chicken and rat
Cunningham The human erythrocyte membrane contains a novel 12-kDa inositol phosphate-binding protein that is an immunophilin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0749443

Country of ref document: EP

REN Ceased due to non-payment of the annual fee